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Background: Traditional microscopic examination of urine or stool for schistosome eggs
lacks sensitivity compared to measurement of schistosome worm-derived circulating
antigens in serum or urine. The ease and non-invasiveness of urine collectionmakes urine
an ideal sample for schistosome antigen detection. In this study several user-friendly,
lateral-flow (LF) based urine assays were evaluated against a composite reference that
defined infection as detection of either eggs in urine or anodic antigen in serum.
Method: In a Tanzanian population with a S. haematobium prevalence of 40–50%
(S. mansoni prevalence <2%), clinical samples from 44 women aged 18 to 35 years
were analyzed for Schistosoma infection. Urine and stool samples were examined
microscopically for eggs, and serum samples were analyzed for the presence of the
anodic antigen. Urines were further subjected to a set of LF assays detecting (circulating)
anodic (CAA) and cathodic antigen (CCA) as well as antibodies against soluble egg
antigens (SEA) and crude cercarial antigen preparation (SCAP).
Results: The urine LF anodic antigen assay utilizing luminescent upconverting reporter
particles (UCP) confirmed its increased sensitivity when performed with larger sample
volume. Qualitatively, the anodic antigen assay performed on 250 µL urine matched the
performance of the standard anodic antigen assay performed on 20 µL serum. However,
the ratio of anodic antigen levels in urine vs. serum of individual patients varied with
absolute levels always higher in serum. The 10 µL urine UCP-LF cathodic antigen assay
correlated with the commercially available urine POC-CCA (40 µL) test, while conferring
better sensitivity with a quantitative result. Urinary antibodies against SEA and SCAP
overlap and correlate with the presence of urinary egg and serum anodic antigen levels.
Conclusions: The UCP-LF anodic antigen assay using 250 µL of urine is an expedient
user-friendly assay and a suitable non-invasive alternative to serum-based antigen testing
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and urinary egg detection. Individual biological differences in the clearance process of
the circulating antigens are thought to explain the observed high variation in the type and
level of antigen (anodic or cathodic) measured in urine or serum. Simultaneous detection
of anodic and cathodic antigen may be considered to further increase accuracy.
Keywords: Schistosoma haematobium, CAA anodic antigen, CCA cathodic antigen, antibody, urine, lateral flow
assay, UCP upconverting reporter particle
INTRODUCTION
Schistosomiasis is a neglected parasitic infection that may affect
over 700 million people worldwide (1), and optimal diagnostic
strategies have still not been established. Accurate diagnosis of
an active Schistosoma infection requires elaborate parasitology
on multiple samples as eggs cluster together and shedding
is irregular (2); these factors are known to limit the sensitivity of
the egg detection methods in urine (i.e., S. haematobium) as well
as stool (i.e., S. mansoni). This traditional diagnostic method of
microscopic examination of urine (3) or stool (4) for schistosome
eggs in medium to low endemic areas lacks sensitivity compared
to measurement of schistosome worm antigen in serum or urine
(5, 6).Maximizing sensitivity becomes particularly pressing in the
setting of low-intensity infections (more common among adults),
and also as efforts to interrupt transmission accelerate (7).
Schistosome circulating anodic and cathodic antigens (CAA and
CCA, respectively) are glycosaminoglycan-like carbohydrates
regurgitated from the gut of live schistosome worms into the
host bloodstream (8). Both antigens are cleared from the human
circulation via the kidneys and can be detected in serum as well as
urine, allowing non-invasive diagnosis. Antigen levels diminish
rapidly following anti-schistosome praziquantel treatment (9,
10). Detection of these antigens has been shown to be more
accurate to identify active and low grade infections and does
not require the analyses of different sample types in case of
unknown species or mixed infection. A urine cathodic antigen
assay is available as a low cost point-of-care test (POC-CCA)
with excellent diagnostic capability for moderate to high-grade
S. mansoni infection (5, 11, 12), but to a lesser extent for
S. haematobium detection (13). This assay is mostly used for
mapping and monitoring of endemic areas (14–16), but also
showed its use in non-endemic countries for individual diagnosis
of e.g. immigrants (17–19).
A more sensitive genus-specific anodic antigen LF assay,
applicable for all Schistosoma species including veterinary
infections, was developed several years ago (20). Multiple studies
have utilized this up-converting phosphor LF assay (UCP-LF
CAA) to investigate prevalence in S. mansoni, S. haematobium,
S. mekongi, and S. japonicum settings using serum, urine, or
both (21–29). The test platform includes a sample preparation
step that allows analysis of increased sample volume providing
ultimate sensitivity down to detection of single worm (single
sex) infections. A study in the People’s Republic of China
showed a sensitivity of >90% for diagnosis of S. japonicum
using the assay on concentrated urine samples, as compared
to a composite reference that defined infection as detection of
either eggs or anodic antigen in serum or urine (30). Anodic
antigen concentrations were approximately 10-fold lower in
urine than in serum similar to what has been described previously
(31).
We sought to determine the performance of several user-
friendly LF based urine assays in a population in which S.
haematobium is endemic. Urine LF assays were evaluated against
a composite reference of either detecting eggs in urine and/or
schistosome anodic antigen in serum. Eggs were detected by
standard urine filtration microscopy and the level of schistosome
anodic antigen in serum was determined using the UCP-LF CAA
assay. We also compared these findings to the commercially-
available POC-CCA urine test, as well as an experimental UCP-
LF urine assay, both detecting the cathodic antigen. In addition,
two rapid UCP-LF antibody assays detecting antibodies against
crude cercarial and soluble egg preparations were evaluated for
use with urine samples.
METHODS
Study Site and Population
This study was conducted in four rural inland villages in
northwest Tanzania in which S. haematobium is highly endemic
(32). The prevalence of S. haematobium infection among
adults in these villages is ∼40–50%, and the prevalence of
S. mansoni infection is ≤2% (25). All women between the
ages of 18 and 35 in each village were invited to receive
free screening for schistosomiasis. Women provided urine,
stool, and blood samples. Urine and stool were examined
microscopically for Schistosoma eggs, and serum was used to
determine schistosome anodic antigen concentration. Urine
samples were further analyzed for anodic and cathodic
antigens and anti-schistosome antibodies. Women were also
screened for HIV and those enrolled in this study were
all HIV-uninfected. Individuals found to be HIV-infected
were given referral letters to the nearest HIV Care and
Treatment Centre, where they could access HIV care free of
charge.
Sample Collection and Field Analysis
All samples were collected between 10:00 a.m. and 2:00 p.m.
on study enrollment days. Women provided at least 25mL
of urine. Ten mL of urine was filtered in the field and
immediately examined microscopically for S. haematobium eggs.
Fifteen mL of urine was placed into Falcon tubes and stored at
−20◦C at the reference laboratory in Mwanza until transport to
Leiden University Medical Center for schistosome antigen and
antibody testing. To test for S. mansoni eggs, five Kato-Katz
slides were prepared from each stool sample, a strategy with a
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sensitivity comparable to testing three stool samples obtained
on separate days (33). Serum was centrifuged and separated
each day upon return to Mwanza and subsequently stored at
−20◦C.
Serum Anodic Antigen Testing in Local
Laboratory
Serum anodic antigen testing using the (UCP-LF) technology
was performed at the National Institute for Medical Research
in Mwanza as previously described (20, 34). In this dry-reagent
format of the assay, 20 µL of serum was used (SCAA20)
(12). Serum was pretreated with an equal volume of 4%
(v/v) trichloroacetic acid (TCA); applied cut-off thresholds are
indicated in Table 1. Cut-offs are derived from Corstjens et
al. (12) and are determined from testing series of negative
samples.
Urine Anodic Antigen Lateral Flow Assays
UCP-LF anodic antigen assays using increasing volumes
of urine were performed at Leiden University Medical
Center as previously described (35). All urine samples were
tested using 10 µL of urine (UCAA10) and 250 µL of
urine (UCAA250) (12). Samples with negative or indecisive
results in the UCAA250 assay were retested using 2,000 µL
of urine (UCAA2000). All samples were extracted with an
equal volume of 4% (v/v) TCA. Concentration of the clear
supernatant was performed using 0.5 and 4mL single-use
10 kD concentration devices (Amicon Ultra Centrifugal
Filters, Millipore Corp) for the UCAA250 and UCAA2000,
respectively. The resulting 20 µL concentrate was used
in the assay. Applied cut-off thresholds are indicated in
Table 1.
Additional Urine Tests
Besides the UCP-LF anodic antigen assay, urine samples were
also examined with four additional tests. The commercially-
available urine point-of-care (POC)-CCA test (Rapid Medical
Diagnostics, Pretoria, South Africa; format 2013, utilizing
chase buffer) was used to evaluate its performance in an S.
haematobium-endemic setting. Furthermore, a prototype UCP-
LF cathodic antigen assay, quantitating cathodic antigen in
urine, was performed with 10 µL urine (UCCA10), following
the same protocol as described for the anodic antigen assay
(UCAA10), but with a cathodic antigen specific UCP reporter
conjugate and LF strips, as described earlier (12). Cut-off
thresholds for the UCCA10 assay are indicated in Table 1. The
UCP-LF cathodic antigen assay has not been explored with
concentrated urines and therefore does not include an indecisive
(potential positive) range; the applied cutoff is according to
the threshold as determined previously with ELISA (36). The
UCCA10 utilizes the same antibody on the UCP reporter as on
the LF strip (mouse monoclonal 54-4C2), whereas the POC-
CCA uses a second antibody on the LF strip (mouse monoclonal
54-5C10). Sample input differs as the POC-CCA requires 40
µL of untreated urine whereas the UCCA10 assay utilizes 10
µL urine which is extracted with an equal volume of TCA
(4% w/v). In addition, two UCP-LF-based assays for antibody









SCAA20 >30 10–30 <10
UCAA10 >30 10–30 <10
UCAA250 >3 1–3 <1
UCAA2000 >0.3 0.1–0.3 <0.1
Cathodic antigen testb
UCCA10 >2,460 <2,460
aAnodic antigen assays utilizing the UCP-LF test platform: SCAA, CAA assay performed
on 20 µL serum; UCAA, CAA assay preformed on respectively 10, 250 and 2000mL
urine.
bCathodic antigen assay utilizing the UCP-LF test platform: UCAA, CCA assay performed
on 10 µL urine.
detection against soluble egg antigens (SEA) and crude cercarial
antigen preparation (SCAP) in urine were applied, as previously
described (12). The cut-off threshold was calculated from 11
samples that were negative in all antigen assays as well as with
microscopy.
Data Analysis
Sensitivity (Sn) and specificity (Sp) were calculated for
each diagnostic test, considering the combined results from
microscopy (egg count) and SCAA20 (serum anodic antigen)
as the “composite reference.” Hence, any positive test result by
urinary microscopy or SCAA20 (indecisive results considered as
negative) was considered a true-positive result. Consequently,
the specificity was set to be 100% for these two assays. To
indicate the weight of indecisive (potentially positive) and
trace results, Sn and Sp were calculated for each test separately
including indecisive or trace results either as positive or negative.
Additionally, the performance of each test was compared to
UCAA2000 and a combination of UCAA2000 and UCCA10
(indecisive results of the UCAA2000 were considered as
negative). The correlation between the two antibody assays was
calculated using the Spearman rho. All statistical analysis were
performed using IBM SPSS Statistics v 23.0 (IBM Corp, Armonk,
NY).
Ethics
This project was approved by the Catholic University for
Health and Allied Sciences/Bugando Medical Centre (Mwanza,
Tanzania), the National Institute for Medical Research (Dar
es Salaam, Tanzania), and Weill Cornell Medical College
(New York, New York). All study participants provided
written informed consent and were given praziquantel on
the day of study enrollment in accordance with World
Health Organization recommendations for treatment of
adults in areas in which schistosome infections are highly
endemic (37).
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RESULTS
Serum Anodic Antigen and Urine
Microscopy Findings—A Composite
Reference
Between June and August 2013, we obtained 39 samples
from women who presented for schistosomiasis screening,
and 5 additional post-treatment samples from women with
a confirmed S. haematobium infection and who received
praziquantel treatment 2 months previously. The distribution of
locally determined serum anodic antigen levels (SCAA20) and
urine microscopy egg-count results are shown in Table 2. Of
the 44 samples, 14 were egg and serum anodic antigen positive.
The serum anodic antigen assay detected 3 additional positives
with concentrations ≥30 pg/mL; 8 other samples were ranked
indecisive of which one had 2 eggs per 10mL. In total, 18 women
met the criteria for the composite reference of S. haematobium
infection, defined as either a positive test result by urine egg
microscopy or a serum anodic antigen level >30 pg/mL. S.
mansoni eggs in stool or urine were not identified in any study
participant.
Urine Anodic Antigen (UCAA) Assay
Results—Performance Utilizing Large
Sample Volume
Urine samples transported to LUMC (the Netherlands) were
analyzed utilizing increased sample volume for enhanced
sensitivity as well as to resolve the status of samples with
indecisive results. Applying the dry reagent cutoff threshold of
30 pg/mL (12), the UCAA10 assay was positive for 4 out of the 44
samples, and indecisive for 6. These 10 positive/indecisive results
were all part of the 18 composite reference positives (Table 3).
The 25-fold larger volume UCAA250 assay identified 16 out of 18
composite reference positives, 2 additional positives not detected
by the UCAA10 assay, and another 3 as indecisive. The 200-
fold-larger volume UCAA2000 assay correctly identified all 18
composite reference positives, as well as 7 additional positives
that were negative by both urine microscopy and serum anodic
antigen. Additionally, 5 indecisive samples were obtained with
the UCAA2000, one also scoring a SCAA20 indecisive result (13
pg/mL). All samples positive with a lower volume UCAA assay
remained positive when retested at a higher volume. Results are
summarized in Figure 1 showing the percentage of positive and
indecisive samples for all applied diagnostics.
Urine Cathodic Antigen Results
In this S. haematobium endemic setting the POC-CCA test
identified 7 positives and 4 traces. These results are in agreement
with the results of the prototype UCP-LF cathodic antigen
assay (UCCA10). All 7 POC-CCA positives and the 3 out of
4 traces tested positive with the UCCA10 assay, which overall
indicated 14 positive samples (Table 4). One UCCA10 negative
sample with a POC-CCA trace result tested positive for anodic
antigen in serum as well as in urine. The POC-CCA identified
only 4 out of 18 composite reference positives, and of the 4
traces, only 1 was also positive by the composite reference.
Table 5 shows the cathodic antigen (UCCA10) and the anodic
TABLE 2 | Urine egg microscopy and serum CAA results for 44 individuals.






SCAA20 Positive 14* 3* 17
Indecisive 1* 7 8
Negative 0 19 19
*Numbers indicate samples included in the composite reference: urine egg microscopy
positive and/or a SCAA20 result >30 pg/mL.
TABLE 3 | Performance of the increased volume UCP-LF anodic antigen assays







UCAA10 Positive 4 0 4
Indecisive 6 0 6
Negative 8 26 34
UCAA250 Positive 16 2 18
Indecisive 0 3 3
Negative 2 21 23
UCAA2000 Positive 18 7 25
Indecisive 0 5 5
Negative 0 14 14
*Composite reference: urine eggmicroscopy positive and/or a SCAA20 result>30 pg/mL.
antigen (UCAA2000) assay results. From the 25 UCAA2000
positives, 9 were also identified with the UCCA10, while the
latter identified 3 additional positives that were not identified
by the UCAA2000, and which were also negative according to
the composite reference. For the few samples with a quantified
level of both antigens, there was no obvious correlation observed
between the absolute levels of the anodic and cathodic antigen in
urine.
Performance of the Urine Anodic and
Cathodic Antigen Tests
Table 6 shows the clinical performance of each test compared
to the composite reference. By definition, the clinical specificity
(Sp) of bothmicroscopy and SCAA20 is 100%. Clinical sensitivity
(Sn) of anodic antigen detection in urine increases when using
larger sample volume. Sp decreases with the increased urine
volume as a consequence of detecting antigen positives that
were not identified with the assays used to define the local
composite reference. Sn and Sp values when using the assumed
most sensitive urine antigen diagnostics as a gold standard are
indicated in Table 7. Values are calculated for either the anodic
antigen only, or for the combined anodic and cathodic antigen
detection results. To indicate the weight of indecisive and trace
results, Sn and Sp were calculated either including indecisive
or trace results as positive or negative. Table 7 indicates Sn and
Sp against the UCAA2000 and the UCAA2000 combined with
the UCCA10. In this table indecisive results obtained with the
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FIGURE 1 | Performance of individual diagnostic tests to identify S. haematobium infection. A composite reference was defined, based on assays performed locally,
ranking samples positive based on either a positive test result by urine egg microscopy and/or a serum anodic antigen level >30 pg/mL.








POC-CCA Positive 7 0 7
Trace 3 1 4
Negative 4 29 33
UCAA2000 are categorized as negative as larger volume testing
was not applied to resolve their status.
Serology Status Determined Through
Antibody Detection in Urine
The two antibody detection assays in urine correlated well
(Figure 2) as was similarly demonstrated in serum in a previous
study (12). Out of the 18 composite reference positives 14 showed
clear reactivity with at least one of the antibody assays. Serology
turned out to be negative in two egg positive cases. One of these
samples (7 eggs per 10mL urine) had a remarkably high level
of the anodic antigen in serum and cathodic antigen in urine,
respectively >10,000 and 5,900 pg/mL as determined with the
SCAA20 (serum) and UCCA10 (urine) assays. In contrast, the
urine anodic antigen level was 27.8 pg/mL (UCAA250), more
than 100-fold less than the concentration in serum. This sample
was also easily identified with the POC-CCA test. The second







UCAA2000 Positive 9 16 25
Indecisive 2 3 5
Negative 3 11 14
sample (5 eggs per 10mL urine) was negative for urine cathodic
antigen, but positive for anodic antigen with levels in serum and
urine showing a 50-fold difference (50 and 1 pg/mL, respectively).
Tentatively, urine antibody assays generally seem reactive at
anodic antigen levels above 100 pg/mL in serum as well as with
the presence of urinary eggs.
Status of Previously Infected,
Praziquantel-Treated Participants
The serum anodic antigen assay (SCAA10) indicated that 3 of the
5 previously infected and treated individuals were still carrying an
active infection, with levels ranging between 10 and 100 pg/mL.
This was confirmed by urine anodic antigen, indicating levels
between 1 and 15 pg/mL. A fourth sample was only positive
for urine cathodic antigen, with a level of 4,500 pg/mL, while
the POC-CCA test was negative. Eggs were not detected in any
of the 5 individuals, but based on the outcome of these tests,
3 individuals remained positive by the composite reference and
the individual with the positive UCCA10 is likely still infected as
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well. Thus, 4 of the 5 recently-treated women would require an
additional drug treatment.
DISCUSSION
Although the number of individuals included in this study was
relatively small (a study limitation), it clearly demonstrates that
the use of larger volumes of urine enhances the sensitivity
of diagnosis with the anodic antigen assay in individuals
with S. haematobium infection. Diagnostic tests performed in
Tanzania identified 18 who met the criteria for the composite
reference, defined here as being urine egg microscopy positive
and/or serum anodic antigen (SCAA20) positive. As a non-
invasive and thus patient-friendly alternative, the UCAA250
assay utilizing 250 µL could be considered. This assay identified
18 positives, 16 of whom were identified by the composite
reference. Allowing for a less than optimal specificity, indecisive
results could be interpreted as positive, which would yield
an additional 3 positive scores. The higher volume format
UCAA2000 confirmed that this would be correct for 2 out of
TABLE 6 | Sensitivity and specificity of individual diagnostic tests vs. the
composite reference.
With indecisives
considered to be negative
With indecisives
considered to be positive
Sn Sp Sn Sp
Microscopya 83% 100% n/a n/a
SCAA20a 94% 100% n/a n/a
UCAA10 22% 100% 56% 100%
UCAA250 89% 92% 89% 81%
UCAA2000 100% 73% 100% 54%
UCCA10 33% 69% n/a n/a
POC-CCA 22% 88% 33% 81%
aSp is 100% by definition as the composite reference assumes 100% specificity for
microscopy and SCAA20 (in total 18 positives)
the 3 indecisive samples. The UCAA250 assay would then have
successfully detected 20 positives out of the 25 samples that
tested positive with the UCAA2000 anodic antigen assay. The
UCAA2000 assay identified all 18 composite reference positive
samples as well as 7 additional positives. However, this assay
is more time-intensive and costly as it requires larger tubes
and concentration devices that are no longer compliant with
micro-centrifuges and tubes. Therefore, we would recommend
accepting a slightly lower sensitivity by using 250 µL urine rather
than 2000 µL. Alternative lower-cost methods to concentrate the
CAA from large urine volume are being explored to improve field
applicability of the UCAA2000 (38).
Utilization of a single, non-invasive urine sample, rather than
performing both urine microscopy and serum anodic antigen
testing, is more user-friendly, less prone to error and likely more
economical. Moreover, because the anodic antigen is genus-
specific, collection and testing of urine only is sufficient for
diagnosis of all Schistosoma species infections. The same may
hold for the cathodic antigen if concentrated, although this
FIGURE 2 | Correlation between SEA and SCAP antibodies.










Sn Sp Sn Sp Sn Sp Sn Sp
Microscopy 60% 100% n/a n/a 50% 100% n/a n/a
SCAA20 68% 100% 96% 95% 57% 100% 83% 100%
UCAA10 16% 100% 40% 100% 13% 100% 33% 100%
UCAA250 72% 100% 80% 95% 60% 100% 67% 93%
UCAA2000 100% 100% 80% 95% 83% 100% 90% 79%
UCCA10 36% 74% n/a n/a 47% 100% n/a n/a
POC-CCAc 20% 89% 32% 84% 23% 100% 37% 100%
aAssuming 100% specificity of the anodic antigen detection by the UCAA2000 (total of 25 positives when indecisive are considered to be negative)
bAssuming 100% specificity of the anodic antigen detection by the UCAA2000 and cathodic antigen detection (UCCA10) (total of 30 positives when indecisive are considered to be
negative)
cPOC-CCA trace results fall under indecisive
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antigen has some additional biological activity due to homology
to Lewis X structures (39).
The commercially available POC-CCA test for urine samples
is recommended for diagnosis of Schistosomamansoni infections.
Use of this assay for diagnosis of S. haematobium infections
shows variable results with generally lower performances than
for S. mansoni (13, 40–43). Our study also documented a lower
sensitivity of this test for the diagnosis of urinary schistosomiasis.
This might be due to lower levels of cathodic antigen produced by
S. haematobium worms as compared to S. mansoni (unpublished
observations). Use of the more sensitive UCP-LF cathodic
antigen assay (UCCA10) indeed increased the number of positive
samples to 14 compared to 7 for the POC-CCA. Importantly, of
4 samples generating a POC-CCA trace result, 3 samples tested
positive with the UCCA10 assay. Clearly, weak signals (traces) in
visually interpreted tests as the POC-CCA may be more difficult
to interpret. However, considering traces as negative resulted in
a higher specificity, but subsequently lower sensitivity, which
may reduce the usefulness of the test for mapping purposes
(44, 45). Overall, the overlap between POC-CCA and UCCA10
results confirm the specificity of the POC-CCA test. The UCP-
LF cathodic antigen test was developed to increase analytical
sensitivity through the application of a luminescent reporter,
and to explore the effect of TCA treatment on the biological
background. Further development of this assay into a high
sensitivity format, identical to the UCP-LF anodic antigen assay
and potentially utilizing larger volumes of urine, may provide
better insight on the ratio of the levels of both antigens in
urine samples. When the cathodic antigen assay is amenable to
larger volume testing, a duplex LF strip detecting both antigens
in a single sample will further increase sensitivity. Moreover,
the relation between the two antigens might provide some
information regarding the infecting species.
When using (rapid) LF based assays, indecisive test results
remain an important issue. For visual assays, weak signals may
be scored as trace by some observers whereas others would score
it as negative. Whether a trace is false positive or true positive
may be difficult to determine without alternative diagnostics.
The intensity of the signal might also vary per production batch
of test strips, as well as whether the manufacturer is targeting
highest sensitivity or specificity of the test. Further, the choice
to rank trace results as a positive or negative will depend on the
goal of the survey (prevalence studies vs. elimination studies) as
well as potential complications of drug treatment. A strength of
the UCP-LF test format is that it utilizes a luminescent reporter
label that requires a reader (scanner) to analyze the LF strip
and generate the test result. Besides providing extra sensitivity
as compared to a visual test, this reader removes operator
interpretation flaws. Moreover, the reader can be set either to
include or exclude indecisive results as positive. This allows
manufacturers to optimize the test for sensitivity and adjust for
specificity by programming the reader.
In contrast to the detection of eggs and circulating worm
antigens, the presence of host antibodies against Schistosoma
derived biomolecules is not necessarily a measure for ongoing
active infection, except in those who would not previously have
been exposed to Schistosoma parasites [i.e., individuals from
non-endemic settings or travelers; (46)]. In the current small
endemic cohort, antibody detection in urine could not contribute
to resolving disputes regarding anodic antigen negatives and
cathodic antigen positives or indecisive/trace results as the
analytical sensitivity of the assay was not sufficient to identify all
infected individuals. This may have been a consequence of setting
relatively high cutoff thresholds. Studies with larger cohorts are
needed to determine accurate values; appropriate thresholds may
also provide insight in potential differences of reactivity against
SCAP and SEA. Although the assay is not yet fully optimized,
this study has demonstrated that the detection of specific host
antibodies in non-invasive urine samples is feasible. This would
constitute a rapid and low cost assay, but it remains to be
determined whether urine would be a good enough alternative
to the more invasive fingerstick blood.
CONCLUSION
The non-invasive UCP-LF anodic antigen (CAA) assay utilizing
250 µL of urine has been demonstrated to be a valid alternative
for the current locally used diagnostic strategy, which is based on
egg microscopy combined with anodic antigen serum analysis.
Furthermore, testing for the presence of the worm derived
anodic antigen in large volume urine samples is a sensitive tool
to monitor treatment efficiency. An important feature of the
UCP-LF antigen urine assay is the potential confirmation of
indecisive test results by using larger sample volumes. Testing for
the presence of the cathodic antigen (CCA) would have added
value also in S. haematobium settings, although more studies
are needed to validate the status of anodic antigen negative and
cathodic antigen positive samples. Anticipated development of a
UCP-LF duplex test combining the anodic and cathodic antigen
may improve sensitivity.
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